Press releases
Curium Completes Patient Enrollment of Phase 3 ECLIPSE Trial Ahead of Schedule
21st November 2023
Latest news, Events and Press Releases
Find all of our recent press releases, stay updated with the latest news and be informed about upcoming events where Curium will be attending.
Please direct any media inquiries to communications@curiumpharma.com
Press releases
Press releases
Curium and PIUR IMAGING announce thyroid imaging partnership in Germany to enable tomographic 3D ultrasound solutions
25th October 2023
Press releases
Curium announces exclusive distribution agreement in Switzerland with b.e. Imaging for PYLCLARI™, an innovative 18F-PSMA PET tracer indicated in adults with prostate cancer
7th September 2023
Press releases
Curium announces achievement of co-primary endpoints in phase 2 of its phase 1/2 SOLAR clinical trial imaging men with histologically-proven prostate cancer using copper Cu 64 PSMA I&T
15th August 2023
Press releases
Curium receives marketing authorization in the EU for Pylclari™, an innovative 18F-PSMA PET tracer indicated in adults with prostate cancer
28th July 2023
Press releases
Curium announces license and development agreement with Lantheus for AI-based PSMA PET software in Europe
25th July 2023
Press releases
Curium announces publication of [18F]DCFPyL versus [18F]fuoromethylcholine results from European phase III Study (PYTHON trial)
21st July 2023
Press releases
Curium receives positive CHMP opinion of PYLCLARI® for primary staging of patients with high-risk PCa prior to initial curative therapy and to localize recurrence of PCa in patients with a suspected recurrence based on increasing serum Prostate-Specific Antigen (PSA) levels after primary treatment with curative intent
26th May 2023
Press releases
Curium announces last patient enrolled in their Phase 1/2 SOLAR clinical trial imaging men with histologically-proven metastatic prostate cancer using copper Cu 64 PSMA I&T
23rd May 2023
Press releases
Curasight and Curium announce global partnership for uTRACE® in prostate cancer
2nd May 2023
Press releases
Curium confirms no supply challenges in North America and Europe for its ECLIPSE Phase 3 clinical trial
14th March 2023
Press releases
Innovation and growing demand for nuclear medicine drives Curium expansion and 10-year commitment to St. Louis, MO
2nd March 2023